Dr. Durant Barrett Abernethy, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 360 Peak One Drive, Suite 260, Frisco, CO 80443 Phone: 970-668-5584 Fax: 970-262-2196 |
David D Biggs, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 360 Peak One Dr Ste 300, Frisco, CO 80443 Phone: 970-668-2360 Fax: 970-668-2361 |
Marc S Shiffman, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 730 Summit Blvd, 101, Frisco, CO 80443 Phone: 970-668-3911 Fax: 970-668-5650 |
Melvin R Stjernholm, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 323 West Main St, Suite 101, Frisco, CO 80443 Phone: 970-668-8970 Fax: 970-470-6630 |
Warren L. Johnson Jr., M.D. Internal Medicine - Interventional Cardiology Medicare: Medicare Enrolled Practice Location: 360 Peak One Drive, Suite 390, Frisco, CO 80443 Phone: 970-668-9772 Fax: 970-668-9774 |
Mark Andrew Norden, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 340 Peak One Drive, Frisco, CO 80443 Phone: 303-885-4673 Fax: 405-948-6507 |
Peter M. Lemis, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 360 Peak One Dr, Suite 390, Frisco, CO 80443 Phone: 970-668-9772 Fax: 970-668-9774 |
Dr. Marc L Schlesinger, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 340 Peak One Drive, Frisco, CO 80443 Phone: 630-291-4749 |
News Archive
How can Facebook aid someone in their weight loss journey? According to recent research from the Arnold School of Health at the University of South Carolina, use of the social media site can be associated with a significant drop in pounds, especially during the critical maintenance period of a weight loss journey, where support from the clinical staff decreases.
Researchers have long questioned why patients with Duchenne muscular dystrophy (DMD) tend to manage well through childhood and adolescence, yet succumb to their disease in early adulthood, or why elderly people who lose muscle strength following bed rest find it difficult or impossible to regain.
Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing oncology therapeutics, today announced the dosing of the first patient in an investigator sponsored Phase I/IIa clinical study of AR-42 (formerly OSU-HDAC42) at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) in adult patients with relapsed or refractory multiple myeloma (MM), chronic lymphocytic leukemia (CLL) or lymphoma.
For the first time, researchers have produced a nearly complete three-dimensional structure for the yeast Nuclear Pore Complex. This discovery represents a major step toward identifying the atomic structure of the NPC, which soon may provide researchers with a better understanding of how the central transport channel functions.
A new rule to restrict legal immigration, published by the Trump administration this month, is sowing confusion and anxiety even among immigrants not directly affected by it, as fear spreads faster than facts, immigration and health policy experts say.
› Verified 8 days ago